BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo
BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo
簡介-Bicryst PharmPharmticals-3月18日,Co撤回了Orladeyo的孤兒藥物產品指定申請
March 18 (Reuters) - BioCryst Pharmaceuticals Inc :
* BIOCRYST PHARMACEUTICALS - ON MARCH 18, CO WITHDREW ITS APPLICATION FOR ORPHAN MEDICINAL PRODUCT DESIGNATION FOR ORLADEYO™ (BEROTRALSTAT) IN THE EU
Source text for Eikon: [ID: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
* BIOCRYST PHARMACEUTICALS - ON MARCH 18, CO WITHDREW ITS APPLICATION FOR ORPHAN MEDICINAL PRODUCT DESIGNATION FOR ORLADEYO™ (BEROTRALSTAT) IN THE EU
Source text for Eikon: [ID: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
March 18 (Reuters) - BioCryst Pharmaceuticals Inc :
* BIOCRYST PHARMACEUTICALS - ON MARCH 18, CO WITHDREW ITS APPLICATION FOR ORPHAN MEDICINAL PRODUCT DESIGNATION FOR ORLADEYO™ (BEROTRALSTAT) IN THE EU
Source text for Eikon: [ID: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;)
路透3月18日電-BioCryst PharmPharmticals Inc:*BioCryst PharmPharmticals-3月18日,CO撤回了其在歐盟為ORLADEYO™(BEROTRALSTAT)指定孤兒藥品的申請Eikon的源文本:[ID:進一步的公司覆蓋範圍:(Reurs.Briefs@thomsonreurs.com;)
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
搶先評論
0 0 0
讚好勁正笑哭社會社會Emm惨惨嬲嬲
輕觸選擇心情
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧
點擊這裡與好友分享
暫無評論,快來留言吧!